During the past decade, SMO, MD GmbH conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 13 clinical trials were completed, i.e. on average, 86.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 9 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SMO, MD GmbH" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "R-Pharm International, LLC" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SMO, MD GmbH" #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Chiesi USA, Inc." with 1 trials as a collaborator and "IQVIA Pvt. Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "SMO, MD GmbH" are "Rheumatoid Arthritis" (5 trials), "Arthritis, Rheumatoid" (2 trials), "Chronic Obstructive Pulmonary Disease" (2 trials), "Type 2 Diabetes Mellitus" (2 trials) and "Active Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "SMO, MD GmbH" in a lesser frequency.

Most popular intervention types in "SMO, MD GmbH" are "Drug" (19 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Insulin Degludec" (2 trials), "LY3209590" (2 trials), "Tirzepatide" (2 trials) and "Adalimumab 40mg q2w" (1 trials). Other intervention names were less common.

The vast majority of trials in "SMO, MD GmbH" are 20 trials for "All" genders.

Currently, there are NaN active trials in "SMO, MD GmbH". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in SMO, MD GmbH, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in SMO, MD GmbH, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".